Biomarker Directed Trial of Temozolomide and Stenoparib in Relapsed SCLC
Biomarker Directed Trial of Temozolomide and Stenoparib in Relapsed SCLC
Recruiting · NCT06681220 · Registry updated 2026-03-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Biomarker Directed Trial of Temozolomide and Stenoparib in Relapsed SCLC | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm, small cell lung carcinoma | Recruiting | Phase 1 / Phase 2 | 2026-03-11 | NCT06681220 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| VA Office of Research and Development | 472 |
11 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA | Philadelphia | United States | 25 |
| Jesse Brown VA Medical Center, Chicago, IL | Chicago | United States | 16 |
| Michael E. DeBakey VA Medical Center, Houston, TX | Houston | United States | 30 |
| Minneapolis VA Health Care System, Minneapolis, MN | Minneapolis | United States | 36 |
| Omaha VA Nebraska-Western Iowa Health Care System, Omaha, NE | Omaha | United States | 14 |
| Richard L. Roudebush VA Medical Center, Indianapolis, IN | Indianapolis | United States | 16 |
| Robley Rex VA Medical Center, Louisville, KY | Louisville | United States | 6 |
| Salisbury W.G. (Bill) Hefner VA Medical Center, Salisbury, NC | Salisbury | United States | 8 |
| VA Ann Arbor Healthcare System, Ann Arbor, MI | Ann Arbor | United States | 24 |
| VA Palo Alto Health Care System, Palo Alto, CA | Palo Alto | United States | 34 |
| VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA | Pittsburgh | United States | 23 |